Fri, Aug 16, 2024
Share Market News August 17: Here is a list of stocks that are likely to be in focus on Friday, August 16, including SBI, Mahindra & Mahindra (M&M), Vedanta Ltd, Hindustan Zinc Ltd (HZL), Punjab National Bank (PNB), Coal India Ltd (CIL), Bharti Hexacom, Capital Small Fina
More >
Wed, Jul 17, 2024
The approval by the US Food & Drug Administration (USFDA) is for Topiramate capsules of strengths 15 mg and 25 mg, Glenmark Pharmaceuticals said in a statement.
Sun, May 05, 2024
The recalled drug is used to help control the symptoms of lung diseases, including asthma, chronic bronchitis and emphysema.
Sun, Apr 14, 2024
The US-based arm of the Mumbai-headquartered drug firm is recalling the affected lot of Diltiazem Hydrochloride extended-release capsules, the US Food and Drug Administration said in its latest Enforcement Report.
Wed, Feb 14, 2024
Total revenue from operations declined to Rs 2,507 crore as compared with Rs 3,100 crore in the year-ago period, Glenmark Pharma said in a statement. The lower sales in the current quarter are mainly on account of a one-time impact on the company's India business, it added.
Tue, Oct 17, 2023
The company has received final approval from the US Food & Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.
Thu, Sep 21, 2023
Glenmark Pharma's big deal, GlenmarkPharma has sold 75% stake in its subsidiary GLS.
Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.
Sun, Sep 10, 2023
Addressing the company's shareholders, he noted that the company will identify potential candidates for development purposes on a global scale as the drug maker moves up the value chain.
Tue, Aug 22, 2023
Glenmark Case: Drug firm Glenmark Pharmaceuticals said it has entered into a pact with the US Department of Justice, Antitrust Division (DOJ) to resolve court proceedings related to the pricing of a drug.
Thu, Oct 06, 2022
The Mumbai-based drug firm has launched the medication under the brand name LOBG and is priced at around Rs 10 per tablet.
Thu, Jul 07, 2022
Which drug has been launched by Glenmark Pharma? Why Glenmark Pharma in Focus Today? Know full details from Brajesh Kumar.
Wed, Mar 30, 2022
Directorate General of GST Intelligence (DGGI) which works under the aegis of the Ministry of Finance has taken action against many big pharma companies in the country for not filing Goods and Services Tax (GST). The pharma giants included are Dr. Reddys Laboratories, Glenmark, Aurobindo Pharma, Mylan and Cipla, as reported by Zee Business’s Tarun Sharma.
Thu, Sep 30, 2021
Cardiovascular disease (CVD) is the leading cause of mortality and accounts for one-third of global deaths. Cardiac has displaced anti-infectives as the leading therapy in the India Pharma Market (IPM).
Fri, Sep 10, 2021
On the eve of Ganesh Chaturthi, Market Experts and Analysts have suggested 6 vignaharta shares which can give huge profits and good returns to the investors in a period of one year.
Wed, Dec 16, 2020
CLSA highlights that it was a muted month for pharma companies as November sales disappoint for the Domestic Market. CLSA says it was a strong month for IPCA Labs; gains from integration of acquired brands for Dr Reddy. Falling active cases meant sales of Covid treatment drugs moderated for Glenmark / Cipla (+16%/-24% MoM). Glenmark saw the highest growth in its coverage in November, but excluding these products, its portfolio fell 1% YoY. Cipla’s core growth was a smaller 5.9% YoY.
Tue, May 12, 2020
The trial completion and study results are expected by July-August this year. Glenmark was the first pharmaceutical company in India to be given an approval by the regulator to conduct Phase 3 clinical trials in India on Favipiravir antiviral tablets for COVID -19 patients.
Mon, May 11, 2020
Glenmark Pharmaceuticals on Monday said it has launched a triple therapy inhaler in the country for patients with chronic obstructive pulmonary disease (COPD).
Mon, May 20, 2019
Several repetitive tasks are fastly disappearing, making the life of HR managers easy. But at the same, they are facing a peculiar challenge from technology - Should they give priority to tech or touch?
Wed, Jun 06, 2018
United Spirits, ADF Foods, CG Power, HCL Tech and Glenmark Pharma are stocks that have come in the news on Wednesday. They may have some positive or negative impact on the market. Here are the stocks that are in news on June 6, 2018:
Mon, Dec 12, 2016
Glenmark and its partner Endo will be entitled to 180 days of generic drug exclusivity for ezetimibe.
Mon, Jul 18, 2016
Domestic pharma players are in stiff competition in US market. Sun Pharma with its taking over of SPARC's ELEPSIA XR, while Dr. Reddy launching Omeprazole and Sodium bicarbonate capsules and that of Glenmark waiting for 62 ANDA's approval, plans to strenghthen their position in the US.
Tue, Jul 12, 2016
Surya Patra and Mehul Sheth of Phillip Capital said, in Q1FY17, pharma industry to see top-line and bottom-line growth by 16% and 24% respectively, primarily due to robust performance from Sun Pharma, led by its product gGleevec.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
